A vial can carry a certificate showing 99% HPLC purity and still hold barely three quarters of its labelled weight in actual peptide. That gap sits between two numbers researchers routinely treat as one: HPLC purity and net peptide content. They measure different things, and mixing them up quietly distorts every concentration, molarity and dose-response curve built downstream.
HPLC purity is a ratio, not a mass
Reversed-phase HPLC separates the components of a dissolved sample and reports each one as a peak. Purity is the area of the target peptide peak divided by the total area of all peaks, usually monitored by UV absorbance at 214 nm or 220 nm, where the peptide bond itself absorbs. A figure of 99.2% means that of everything the detector saw, 99.2% was the target sequence and 0.8% was peptide-related impurity: deletion sequences, truncated chains, oxidised variants, diastereomers formed during synthesis.
Two limits follow from the method itself. First, the detector only reports what elutes and absorbs. Water, most inorganic salts and counter-ions are effectively invisible at these wavelengths, so they never enter the calculation. Second, purity compares peptide species to each other, not milligrams to milligrams. A vial holding 5 mg of peptide material at 99% purity and a vial holding 8 mg at 99% purity produce identical chromatograms in relative terms. The purity figure cannot tell them apart.
Which is why HPLC purity alone cannot answer the question researchers actually need answered: how much peptide is in this vial?
Net peptide content: what the powder actually is
Net peptide content (sometimes just peptide content) is the fraction of the gross powder mass that consists of peptide. The remainder is not contamination in the ordinary sense. It is the predictable residue of synthesis and lyophilisation:
- Water of hydration. Lyophilised peptides are hygroscopic. Bound and adsorbed water routinely accounts for several percent of gross mass, more for strongly hydrophilic sequences.
- Counter-ions. Peptides purified by reversed-phase HPLC in trifluoroacetic acid buffers are usually isolated as trifluoroacetate salts. Every basic residue (arginine, lysine, histidine, plus the N-terminus) can carry a TFA counter-ion at roughly 114 Da each. For a short, basic peptide this alone can be 10 to 20% of the mass. Acetate salts behave similarly at a lower mass penalty.
- Residual salts and solvents. Traces of buffer components and organic solvent survive lyophilisation in small but measurable amounts.
For typical synthetic peptides, net peptide content falls somewhere between 60% and 85% of gross mass. It is batch-specific: two syntheses of the same sequence, purified and dried under slightly different conditions, carry different water and counter-ion loads. A sequence rich in basic residues sits at the low end; a short, neutral sequence dried aggressively sits at the high end. None of this shows up on a chromatogram.
A worked example
Consider a vial labelled 10 mg, with a COA stating 99% HPLC purity and 78% net peptide content.
- Gross powder mass: 10 mg.
- Peptide material: 10 mg × 0.78 = 7.8 mg. The remaining 2.2 mg is water, counter-ions and residual salts.
- Target peptide: 7.8 mg × 0.99 = 7.72 mg. The other 0.08 mg is peptide-related impurity.
The vial contains 7.72 mg of the target sequence, not 10 mg. Reconstitute that powder in 2 mL of solvent on the assumption of 10 mg and the assumed concentration is 5 mg/mL; the actual concentration is 3.86 mg/mL, nearly 23% lower than assumed. For a peptide such as semaglutide, with a molecular mass around 4.1 kDa, the same error carries straight into molarity: an assumed 1.22 mM stock is in reality about 0.94 mM.
A concentration error of that size is not cosmetic. In a receptor-binding assay it shifts the apparent EC50 by the same proportional factor, close to 1.3-fold in this example. In a concentration-response design across cell cultures it compresses or stretches the entire curve. And because net content varies batch to batch, the error is not even consistent. It changes every time a new vial enters the experiment.
How net content is actually measured
Net peptide content cannot be read off an HPLC trace. It needs an orthogonal, mass-based method.
Nitrogen determination. Every peptide has a known nitrogen fraction calculable from its sequence. Combustion (Dumas) or Kjeldahl analysis measures total nitrogen in a weighed sample; dividing measured nitrogen by the theoretical nitrogen fraction yields the peptide mass. The method is robust but assumes all nitrogen present belongs to the peptide, so nitrogen-containing buffer residues bias it high.
Amino-acid analysis (AAA). The reference method. A weighed sample is hydrolysed to completion in strong acid, classically 6 M HCl at 110 °C over a 24-hour incubation, and the liberated amino acids are quantified against calibrated standards. Because the stable amino acids are counted directly, AAA gives both an identity check (does the composition match the sequence?) and an absolute peptide mass. Tryptophan and cysteine are degraded by hydrolysis and excluded from the calculation.
Supporting figures sometimes appear alongside: Karl Fischer titration for water content, ion chromatography for counter-ion percentage. A COA reporting HPLC purity, mass spectrometry for identity, and AAA or nitrogen-based content describes the vial far more completely than one built on a chromatogram alone. How to read and cross-check those documents, and how to spot ones that do not hold up, is covered in the guide to verifying peptide purity and understanding lab reports.
Why this matters at the bench
Every quantitative use of a peptide starts from an assumed mass. If that assumption is gross vial mass rather than net peptide mass, three problems follow.
Molarity is wrong from the first pipetting step. A concentration error made at reconstitution cannot be corrected later by careful serial dilution; every point on the dilution series inherits the same proportional error. The arithmetic of accounting for net content belongs at the reconstitution stage, alongside solvent choice and storage. The practical procedure is laid out in the laboratory guide to reconstitution and storage.
Batch-to-batch comparisons quietly fail. Two batches at identical HPLC purity but 68% and 82% net content differ in delivered peptide by roughly a fifth. An experiment repeated across those batches at equal gross mass is not a replicate. It is a hidden concentration variable. Published cell-culture work that reports activity per milligram of powder, without stating whether the figure is net or gross, carries exactly this ambiguity.
Counter-ions are not always inert. Trifluoroacetate at the levels found in TFA-salt peptides has been reported to affect sensitive cell-culture systems in published work, which is why some studies specify acetate-salt material. Knowing the counter-ion is part of knowing the reagent.
What to ask a supplier for
A purity percentage is the start of a specification, not the end of one. For quantitative work, the useful requests are specific:
- Net peptide content for the specific batch, with the method stated (AAA or nitrogen determination, not an estimate).
- Counter-ion identity (TFA or acetate) and, ideally, its percentage.
- Water content, if determined.
- The HPLC conditions behind the purity figure: column, gradient, detection wavelength. A purity number without its conditions is hard to reproduce or compare.
- Mass spectrometry confirming identity, since a pure peak of the wrong sequence is still the wrong reagent.
Where batch-specific content data is not available, the defensible fallback is to treat net content as an explicit assumption: stated in the methods section, held constant within an experiment, and never silently equated with 100%. The peptides discussed here, along with the rest of the catalogue, are available in the shop for laboratory research use.
All products are supplied strictly for in-vitro laboratory research use only. Not for human or veterinary use.